Jazz Pharmaceuticals plc: JAZZ PHARMACEUTICALS ANNOUNCES FULL YEAR AND FOURTH QUARTER 2021 FINANCIAL RESULTS

DUBLIN, March 1, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and fourth quarter of 2021 and provided financial guidance for

Related Keywords

Germany ,Japan ,United Kingdom ,Italy ,Ireland ,Dublin ,Switzerland ,France ,Spain ,Kristin Bhavnani ,Andrean Flynn ,Redx Pharma ,Erwinaze Erwinase ,Oxybate Xywav ,Rob Iannone ,Epidiolex Epidyolex ,Bruce Cozadd ,Division Of Corporation ,Roche Ltd ,Jazz Pharmaceuticals ,Data Monitoring Committee ,Head Of Global Corporate Communications ,Gw Pharmaceuticals ,Nasdaq ,Company Annual Report On Form ,Exchange Commission ,Prnewswire Jazz Pharmaceuticals ,Springworks Therapeutics Inc ,Company Quarterly Report On Form ,Supplemental Biologics License Application ,Real Time Oncology Review ,Orphan Drug Exclusivity ,Idiopathic Hypersomnia ,Myoclonic Atonic Seizures ,Book Listed ,American Society ,Hematology Annual Meeting ,New Drug Application ,Fast Track Designation ,Corporation Finance ,Effective Tax ,Springworks Therapeutics ,Independent Data Monitoring Committee ,Own Equity ,Convertible Instruments ,Exchangeable Senior ,Exchangeable Senior Notes ,Ended December ,Jazz Pharmaceutical ,Adjusted Consolidated ,Jazz Pharmaceutical Securities ,Quarterly Report ,Annual Report ,Certain Line Items ,United Kingdom Finance Act ,Net Debt ,Euro Term Loan ,Pro Forma ,Leverage Ratio ,Consolidated Adjusted ,Adjusted Debt ,Global Corporate ,Jazz ,Pharmaceuticals ,Azz ,Nnounces ,Bull ,Ear ,Fourth ,Quarter ,021 ,Financial ,Results ,